It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

The research got the thrust after the Department of Biotechnology (DBT), Ministry of Science and Technology and Indian Space ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Dr Jitendra Singh is the minister of state for science and technology and earth sciences Exclusive Interview/ Dr Jitendra Singh, minister of state for science and technology and earth sciences IN ...

Union Minister Dr. Jitendra Singh called on the States to establish “BioE3 Cells” as part of India’s biotechnology revolution ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology (DBT).

The biotechnology trade journal Fierce Biotech ... largest rates of return in venture capital are in the life sciences space, and it comes in the same time frame and speed as it does in IT ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Last year was a surprisingly big one for legal decisions impacting the biotechnology transactions and licensing space. Given that most biotech ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...